ClinicalTrials.Veeva

Menu

Intrathecal Chloroprocaine for Lower Limb Arthroplasty

H

Hôpital de la Croix-Rousse

Status

Completed

Conditions

Lower Limb Arthroplasty Under Chloroprocaine Spinal Anesthesia

Treatments

Drug: Chloroprocaine Injection

Study type

Observational

Funder types

Other

Identifiers

NCT05365074
CSE-HCL 22_729

Details and patient eligibility

About

This study evaluates the perioperative course in adult patients undergoing total or partial knee arthroplasty, or total hip arthroplasty under chloroprocaine spinal anesthesia.

Full description

This study evaluates the failure rate of spinal anesthesia, the duration of surgical anesthesia, the needs for complementary intraoperative analgesia, the time for recovery, the incidence of urinary retention, postoperative nausea and vomiting, and length of stay in the recovery room in patients operated for knee or hip arthroplasty under spinal anesthesia with chloroprocaine 50 mg.

Enrollment

65 patients

Sex

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult patients
  • with spinal anesthesia using 50 mg of chloroprocaine
  • operated for total knee, unicompartment knee or anterior access hip arthroplasty
  • in the period of years 2020 - 2021

Exclusion criteria

  • expressed disagreement to to participate after receiving information notice

Trial design

65 participants in 1 patient group

chloroprocaine anesthesia for arthroplasty
Description:
patients having predicted uncomplicated surgery for total or unicompartment knee arthroplasty of anterior access total hip arthroplasty, operated under spinal anesthesia with 50 mg of chloroprocaine
Treatment:
Drug: Chloroprocaine Injection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems